McKesson Corporation (MCK) is currently trending in the stock market, consistently outperforming competitors on strong trading days. Key players like Isthmus Partners LLC, Vinva Investment Management Ltd, Peterson Wealth Management, BNP Paribas, and others have invested largely in MCK. The corporation has also announced the sale of two of its assets; Rexall and Well.ca to Birch Hill Equity Partners. Institutional owners heavily favor the company, holding close to 88%. The MCK stock is considered a top value and a great long-term investment by market experts. Fiscal 2025 reports show promising results with Q2 showcasing a beat of the earnings and revenue estimates. Predictions from billionaire stockholders, Cliff Asness and Ray Dalio, deem MCK as one of the best stocks to purchase. A surge in its year-to-date stock gains is also notable. Despite some underperformance and revenue missing estimates, the corporation remains resilient with strong Q2 earnings growth and dividend increments. Future outlook appears robust on the U.S. pharma strength.
Mckesson Corporation MCK News Analytics from Tue, 07 May 2024 07:00:00 GMT to Sat, 30 Nov 2024 11:09:56 GMT -
Rating 8
- Information 8
- Rumor 2
